Authors
Loading...
Randomized trial reveals no significant clinical benefit of penicillamine in boys with Duchenne muscular dystrophy, indicating the therapy does not alter disease progression.
Robert I. Roelofs (1979) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: